major indexes slipped into bear territory. And the Nasdaq still is down about 27% since the start of January. But these times won't last forever. Bull markets eventually follow bear markets.
We don't know when this transition will happen. But it's still a great idea to plan for it. Especially since so many companies with solid long-term stories have seen their valuations plummet. And some players have exciting catalysts ahead. So, as we approach the end of 2022, let's take a look at five top stocks to buy before ringing in the new year.
1. Amazon
Amazon (NASDAQ: AMZN) is a leader in two markets set to grow in the double-digits this decade: e-commerce and cloud computing. These businesses have helped Amazon grow earnings into the billions of dollars over time.
But today's higher inflation and other troubles like supply chain issues have been weighing on Amazon. As a result, Amazon's reported declines in operating income. And free cash flow has turned to an outflow. This is painful in the short term. The stock has slipped nearly 40% so far this year.
The good news is the long-term picture remains bright. Amazon has the market position and financial resources to weather these times. The company's revenue still is growing. And members of its Prime membership program are spending more and more on Amazon. Amazon also is strengthening its cost structure. This will be a plus down the road.
Today, Amazon shares are trading for around their cheapest in relation to sales in the past six years. So, the best deal this holiday season may be on Amazon shares.
2. Teladoc Health
Teladoc Health (NYSE: TDOC) sank 63% this year. The telemedicine leader disappointed investors with two billion-dollar non-cash goodwill impairment charges. This deepened investors' worries about the company's lack of profitability.
But the toughest times may be behind Teladoc. In the third quarter, Teladoc narrowed its net loss. The company's revenue and visits continued to climb in the double digits. And Teladoc said deal size today is about 50% bigger than the average deal a year ago.
Companies hurt by today's economic environment and coronavirus disruptions have taken longer than expected to finalize their Teladoc plans. These are temporary issues. And when the situation improves, Teladoc could see a clear rebound. As it stands, the company has managed to increase U.S. member numbers and revenue per member from quarter to quarter.
Right now, Teladoc shares are trading at 2.3 times sales. This is nearly their lowest ever by this measure. Considering growth prospects, now looks like a good time to get in on this recovery story